Therefore, considering the advancements in the field, it appears to be the proper time to conduct a comprehensive reappraisal of the role of AFP testing in HCC surveillance, particularly in determining its effectiveness in improving survival rates and facilitating curative treatments for HCC patients. Here, AFP is linked to hepatocellular carcinoma.